Pannexin 1 inhibitor

Pannexin 1 inhibitor has been studied in 1 paper since 2026: none in people yet, 1 in animals; 1 in the past year. The research so far is in animals. The newest paper, Jul 28, 2026: “Pannexin1 promotes cellular senescence by triggering mtDNA release to activate the cGAS-STING pathway”.

Intervention

1 paper studies it3 findingsUpdated

See all 1 papers on pannexin 1 inhibitor

At a glance

The findings reach mice, none yet in people. 1 lab in 1 country.

None of its findings points the other way.

Mice: a single group. Cells, worms or flies and humans: nothing yet.
  • 1 lab in 1 country
  • Funders: Basic and Applied Basic Research Foundation of Guangdong Province and 6 more
  • Animals1

What did studies of pannexin 1 inhibitor find?

3

Studies of pannexin 1 inhibitor measured 3 outcomes: progression from acute kidney injury to chronic kidney disease, renal fibrosis and cellular senescence.

Progression from acute kidney injury to chronic kidney disease

downin mice1

1 study
  1. Pannexin 1 inhibitor decreases progression from acute kidney injury to chronic kidney disease in mice (renal ischemia/reperfusion injury model).

    “In mouse models of renal ischemia/reperfusion injury, pharmacological inhibition of Panx1 or STING alleviates renal tubular senescence, fibrosis, and the pathological progression from AKI to CKD.”

    Animalsrenal ischemia/reperfusion injury modelkidney

    Pannexin1 promotes cellular senescence by triggering mtDNA release to activate the cGAS-STING pathway

    Biochimica et biophysica acta. Molecular basis of disease

More on Progression from acute kidney injury to chronic kidney disease

Renal fibrosis

downin mice1

1 study
  1. Pannexin 1 inhibitor decreases renal fibrosis in mice (renal ischemia/reperfusion injury model).

    “In mouse models of renal ischemia/reperfusion injury, pharmacological inhibition of Panx1 or STING alleviates renal tubular senescence, fibrosis, and the pathological progression from AKI to CKD.”

    Animalsrenal ischemia/reperfusion injury modelkidney

    Pannexin1 promotes cellular senescence by triggering mtDNA release to activate the cGAS-STING pathway

    Biochimica et biophysica acta. Molecular basis of disease

More on Renal fibrosis

Cellular senescence

downin mice1

1 study
  1. Pannexin 1 inhibitor decreases cellular senescence in mice (renal ischemia/reperfusion injury model).

    “In mouse models of renal ischemia/reperfusion injury, pharmacological inhibition of Panx1 or STING alleviates renal tubular senescence, fibrosis, and the pathological progression from AKI to CKD.”

    Animalsrenal ischemia/reperfusion injury modelrenal tubule

    Pannexin1 promotes cellular senescence by triggering mtDNA release to activate the cGAS-STING pathway

    Biochimica et biophysica acta. Molecular basis of disease

More on Cellular senescence

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 1Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 01 paper in 12 months